Alkharabsheh, O., & Frankel, A. E. (2019). Clinical Activity and Tolerability of SL-401 (Tagraxofusp): Recombinant Diphtheria Toxin and Interleukin-3 in Hematologic Malignancies. Biomedicines.
शिकागो स्टाइल उद्धरणAlkharabsheh, Omar, और Arthur E. Frankel. "Clinical Activity and Tolerability of SL-401 (Tagraxofusp): Recombinant Diphtheria Toxin and Interleukin-3 in Hematologic Malignancies." Biomedicines 2019.
एमएलए उद्धरणAlkharabsheh, Omar, और Arthur E. Frankel. "Clinical Activity and Tolerability of SL-401 (Tagraxofusp): Recombinant Diphtheria Toxin and Interleukin-3 in Hematologic Malignancies." Biomedicines 2019.
चेतावनी: ये उद्धरण हमेशा 100% सटीक नहीं हो सकते हैं.